Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study

Basit Öğe Kaydı
dc.contributor.authorTaşkın, Salih
dc.contributor.authorÇoban, Gonca
dc.contributor.authorAyhan, Ali
dc.contributor.authorTopuz, Samet
dc.contributor.authorAkbayır, Özgür
dc.contributor.authorŞahin, Hanifi
dc.contributor.authorSarı, Mustafa Erkan
dc.date.accessioned2024-06-12T10:05:18Z
dc.date.available2024-06-12T10:05:18Z
dc.date.issued2020
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: To determine prognostic factors for women with ovarian carcinosarcoma (OCS). Material and Methods: A multicenter, retrospective department database review was performed to identify patients with OCS at eight gynecologic oncology centers inTurkey. Demographic, clinicopathological, and survival data were collected. Results: We identified 94 patients with OCS. The median agewas 60.0 years (range, 31-78), and the median follow-up duration was 36.0 months (range, 4-188). After primary cytoreductive surgery, 61(64.9%) patients had ?1 cm of residual disease (optimal debulking), whereas 33 (35.1%) had >1 cm of residual disease (suboptimal debulking). For the entire cohort, the 5-year progression free survival (PFS) rate was 25.2%, whereas the 5-year overall survival (OS) rate was49.4%. Women with optimal cytoreduction had a median PFS of 41.0 months (95% Confidence Interval [CI]: 19.71-62.28, Standard Error [SE]:10.86) compared with women with suboptimal cytoreduction who had a median PFS of 15.0 months (95% CI: 8.79-21.21, SE: 3.16; p=0.011).The 5 year OS rate for women with optimal cytoreduction was significantly higher than that of women with suboptimal debulking (57.6% vs.33.9%; p=0.005). Positive peritoneal cytology (hazard ratio [H]: 2.35, 95% CI: 1.19-4.63; p=0.013) and suboptimal cytoreduction (H: 2.61,95% CI: 1.32-4.99; p=0.004) were independent risk factors for decreased OS. Conclusion: Suboptimal cytoreduction seems to be an independent prognostic factor for decreased OS in women with OCS.en_US
dc.identifier.doi10.37047/jos.2019-73073
dc.identifier.endpage86en_US
dc.identifier.issn2651-4532
dc.identifier.issue2en_US
dc.identifier.startpage78en_US
dc.identifier.trdizinid355179en_US]
dc.identifier.urihttps://doi.org/10.37047/jos.2019-73073
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/355179
dc.identifier.urihttps://hdl.handle.net/20.500.14551/13346
dc.identifier.volume6en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofJournal of oncological sciencesen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleOptimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu